S. Kinnunen, P. Karhapää, A. Juutilainen, P. Finne, and I. Helanterä, Secular Trends in Infection-Related Mortality after, Kidney Transplantation. CJASN, vol.13, issue.5, pp.755-62, 2018.

S. Juan, R. Aguado, J. M. Lumbreras, C. Díaz-pedroche, C. López-medrano et al., Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group, Am J Transplant, vol.7, issue.4, pp.964-71, 2007.

C. Van-delden, S. Stampf, H. H. Hirsch, O. Manuel, P. Meylan et al., Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study, Clin Infect Dis

K. R. Jackson, J. D. Motter, S. Bae, A. Kernodle, J. J. Long et al., Characterizing the landscape and impact of infections following kidney transplantation, American Journal of Transplantation


J. A. Fishman, Infection in Solid-Organ Transplant Recipients, New England Journal of Medicine, vol.357, issue.25, pp.2601-2615, 2007.

S. Sagedal, K. P. Nordal, A. Hartmann, M. Degré, E. Holter et al., A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients, Transplantation, vol.70, issue.8, pp.1166-74, 2000.

I. B. Rabe, B. S. Schwartz, E. C. Farnon, S. A. Josephson, A. B. Webber et al., Fatal Transplant-Associated West Nile Virus Encephalitis and Public Health Investigation-California, Transplantation, vol.96, issue.5, pp.463-471, 2010.

S. Huprikar, E. Bosserman, G. Patel, A. Moore, S. Pinney et al., Donor-Derived Trypanosoma cruzi Infection in Solid Organ Recipients in the United States, American Journal of Transplantation, vol.13, issue.9, pp.2418-2443, 2001.

F. A. Abanyie, E. B. Gray, K. Carpini, A. Yanofsky, I. Mcauliffe et al., Donor-Derived Strongyloides stercoralis Infection in Solid Organ Transplant Recipients in the United States, American Journal of Transplantation, vol.15, issue.5, pp.1369-75, 2009.

, Surveillance of antimicrobial, SURVEILLANCE REPORT

K. Keven, A. Basu, L. Re, H. Tan, M. A. Fung et al., Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation, Transplant Infectious Disease, vol.6, issue.1, pp.10-14, 2004.

L. Albano, S. Bretagne, M. Mamzer-bruneel, I. Kacso, M. Desnos-ollivier et al., Evidence That Graft-Site Candidiasis after Kidney Transplantation Is Acquired during Organ Recovery: A Multicenter Study in France, Clin Infect Dis, vol.48, issue.2, pp.194-202, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00676313

A. Scemla and V. Manda, Infectious complications after kidney transplantation, Nephrol Ther, vol.15, issue.1, pp.37-42, 2019.

C. Kotton, D. Kumar, A. Caliendo, S. Huprikar, S. Chou et al., The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation, Transplantation, vol.102, issue.6, pp.900-931, 2018.

V. Nickeleit, H. K. Singh, P. Randhawa, C. B. Drachenberg, R. Bhatnagar et al., The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations, JASN, vol.29, issue.2, pp.680-93, 2018.

H. H. Hirsch and P. S. Randhawa, BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice, Clinical Transplantation, vol.33, issue.9, p.13528, 2019.

R. San-juan, P. Comoli, S. Caillard, B. Moulin, H. H. Hirsch et al., Epstein-Barr virus-related posttransplant lymphoproliferative disorder in solid organ transplant recipients, Clinical Microbiology and Infection, vol.20, issue.s7, pp.109-127, 2014.

U. D. Allen and J. K. Preiksaitis, Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice, Clinical Transplantation, vol.33, issue.9, p.13652, 2019.

P. G. Pappas, B. D. Alexander, D. R. Andes, S. Hadley, C. A. Kauffman et al., Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET), Clin Infect Dis, vol.50, issue.8, pp.1101-1112, 2010.

N. Kamar, J. Selves, J. Mansuy, L. Ouezzani, J. Péron et al., Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients, New England Journal of Medicine, vol.358, issue.8, pp.811-818, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00409083

R. Schorn, M. Höhne, A. Meerbach, W. Bossart, R. P. Wüthrich et al., Chronic Norovirus Infection after Kidney Transplantation: Molecular Evidence for Immune-Driven Viral Evolution, Clin Infect Dis, vol.51, issue.3, pp.307-321, 2010.

D. Roos-weil, K. Ambert-balay, F. Lanternier, M. Mamzer-bruneel, D. Nochy et al., Impact of Norovirus/Sapovirus-Related Diarrhea in Renal Transplant Recipients Hospitalized for Diarrhea, Transplantation, vol.92, issue.1, pp.61-69, 2011.

J. Gavalda, O. Len, S. Juan, R. Aguado, J. M. Fortun et al., Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study, Clin Infect Dis, vol.41, issue.1, pp.52-61, 2005.

F. López-medrano, M. Fernández-ruiz, J. T. Silva, P. L. Carver, and E. Delden-c-van,-merino, Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study, American Journal of Transplantation, vol.16, issue.11, pp.3220-3254, 2016.

, Cryptococcosis in Solid Organ Transplant Recipients: Current State of the Science | Clinical Infectious Diseases | Oxford Academic, 2019.

C. Bourély, T. Coeffic, J. Caillon, S. Thibaut, G. Cazeau et al., Trends in antimicrobial resistance among Escherichia coli from defined infections in humans and animals, J Antimicrob Chemother, vol.75, issue.6, pp.1525-1534, 2020.

G. A. Eschenauer, E. J. Kwak, A. Humar, B. A. Potoski, L. G. Clarke et al., Targeted Versus Universal Antifungal Prophylaxis Among Liver Transplant Recipients, American Journal of Transplantation, vol.15, issue.1, pp.180-189, 2015.

V. Calvo, J. M. Borro, P. Morales, A. Morcillo, R. Vicente et al., Antifungal Prophylaxis During the Early Postoperative Period of Lung Transplantation, Chest, vol.115, issue.5, pp.1301-1305, 1999.

V. Monforte, A. Roman, J. Gavalda, C. Bravo, L. Tenorio et al., Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors, The Journal of Heart and Lung Transplantation, vol.20, issue.12, pp.1274-81, 2001.

G. Pellé, S. Vimont, P. P. Levy, A. Hertig, N. Ouali et al., Acute Pyelonephritis Represents a Risk Factor Impairing Long-Term Kidney Graft Function, American Journal of Transplantation, vol.7, issue.4, pp.899-907, 2007.

U. Erdbrügger, I. Scheffner, M. Mengel, A. Schwarz, H. Haller et al., Long-term impact of CMV infection on allografts and on patient survival in renal transplant patients with protocol biopsies, American Journal of Physiology-Renal Physiology, vol.309, issue.11, pp.925-957, 2009.

R. Parasuraman and K. Julian, Urinary Tract Infections in Solid Organ Transplantation, American Journal of Transplantation, vol.13, issue.s4, pp.327-363, 2013.

, Urinary Tract Infections in Transplant Recipients, 2019.

F. Lanternier, F. Ader, B. Pilmis, E. Catherinot, S. Jarraud et al., Legionnaire's Disease in Compromised Hosts, Infect Dis Clin North Am, vol.31, issue.1, pp.123-158, 2017.

M. Helfrich, P. Dorschner, K. Thomas, V. Stosor, and M. G. Ison, A retrospective study to describe the epidemiology and outcomes of opportunistic infections after abdominal organ transplantation, Transplant Infectious Disease, vol.19, issue.3, p.12691, 2017.

P. Attias, G. Melica, D. Boutboul, D. Castro, N. Audard et al., Risk Factors, and Outcomes of Opportunistic Infections after Kidney Allograft Transplantation in the Era of Modern Immunosuppression: A Monocentric Cohort Study, Journal of Clinical Medicine, vol.8, issue.5, p.594, 2019.

A. Y. Peleg, S. Husain, E. J. Kwak, F. P. Silveira, M. Ndirangu et al., Opportunistic Infections in 547 Organ Transplant Recipients Receiving Alemtuzumab, a Humanized Monoclonal CD-52 Antibody, Clin Infect Dis, vol.44, issue.2, pp.204-216, 2007.

D. Castro, N. Xu, F. Porcher, R. Pavie, J. Molina et al., Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis: a case-control study, Clin Microbiol Infect, vol.16, issue.9, pp.1375-1382, 2010.

G. S. Lipshutz, H. Mahanty, S. Feng, R. Hirose, P. G. Stock et al., BKV in Simultaneous Pancreas-Kidney Transplant Recipients: A Leading Cause of Renal Graft Loss in First 2 Years Post-Transplant, American Journal of Transplantation, vol.5, issue.2, pp.366-73, 2005.

G. N. Forrest, P. Bhalla, E. E. Debess, K. L. Winthrop, S. R. Lockhart et al., Cryptococcus gattii infection in solid organ transplant recipients: description of Oregon outbreak cases, Transpl Infect Dis, vol.17, issue.3, pp.467-76, 2015.

K. A. Marr, Y. Sun, A. Spec, N. Lu, A. Panackal et al., Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States, Clin Infect Dis, vol.70, issue.2, pp.252-61, 2020.

R. T. Neff, R. M. Jindal, D. Y. Yoo, F. P. Hurst, L. Y. Agodoa et al., Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia, Transplantation, vol.88, issue.1, pp.135-176, 2009.

S. Chou, Acquisition of Donor Strains of Cytomegalovirus by Renal-Transplant Recipients, New England Journal of Medicine, vol.314, issue.22, pp.1418-1441, 1986.

M. A. Schnitzler, J. A. Lowell, K. L. Hardinger, S. B. Boxerman, T. C. Bailey et al., The Association of Cytomegalovirus Sero-Pairing with Outcomes and Costs Following Cadaveric Renal Transplantation Prior to the Introduction of Oral Ganciclovir CMV Prophylaxis, American Journal of Transplantation, vol.3, issue.4, pp.445-51, 2003.

M. Matignon, F. Botterel, V. Audard, B. Dunogue, K. Dahan et al., Outcome of Renal Transplantation in Eight Patients with Candida sp. Contamination of Preservation Fluid, American Journal of Transplantation, vol.8, issue.3, pp.697-700, 2008.

S. M. Hosseini-moghaddam, M. Shokoohi, G. Singh, S. F. Dufresne, A. Boucher et al., A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant Recipients, Clin Infect Dis, vol.68, issue.8, pp.1320-1326, 201908.

M. J. George, D. R. Snydman, B. G. Werner, J. Griffith, M. E. Falagas et al., The Independent Role of Cytomegalovirus as a Risk Factor for Invasive Fungal Disease in Orthotopic Liver Transplant Recipients, The American Journal of Medicine, vol.103, issue.2, pp.106-119, 1997.

F. K. Port, J. L. Bragg-gresham, R. A. Metzger, D. M. Dykstra, B. W. Gillespie et al., Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors, Transplantation, vol.74, issue.9, pp.1281-1287, 2002.

J. W. Schneider and D. P. Dittmer, Diagnosis and Treatment of Kaposi Sarcoma, Am J Clin Dermatol, vol.18, issue.4, pp.529-568, 2017.

L. C. Mcdonald, D. N. Gerding, S. Johnson, J. S. Bakken, K. C. Carroll et al., Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA), Clin Infect Dis, vol.66, issue.7, pp.1-48, 2018.

B. De-pauw, T. J. Walsh, J. P. Donnelly, D. A. Stevens, J. E. Edwards et al., Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Clin Infect Dis, vol.46, issue.12, pp.1813-1834, 2008.

A. Alanio, P. M. Hauser, K. Lagrou, W. Melchers, J. Helweg-larsen et al., ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients, J Antimicrob Chemother, vol.71, issue.9, pp.2386-96, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01405217

A. Humar, M. Michaels, and A. Id, Working Group on Infectious Disease Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation, Am J Transplant, vol.6, issue.2, pp.262-74, 2006.

S. Mawhorter and M. H. Yamani, Hypogammaglobulinemia and infection risk in solid organ transplant recipients. Current Opinion in Organ Transplantation, vol.13, pp.581-585, 2008.

V. Nickeleit, T. Klimkait, I. F. Binet, P. Dalquen, D. Zenero et al., Testing for Polyomavirus Type BK DNA in Plasma to Identify Renal-Allograft Recipients with Viral Nephropathy, New England Journal of Medicine, vol.342, issue.18, pp.1309-1324, 2000.

G. E. Bignardi, Risk factors for Clostridium difficile infection, Journal of Hospital Infection, vol.40, issue.1, pp.1-15, 1998.

A. N. Ananthakrishnan, Clostridium difficile infection: epidemiology, risk factors and management, Nature Reviews Gastroenterology & Hepatology, vol.8, issue.1, pp.17-26, 2011.

G. J. Li, J. Trac, S. Husain, O. Famure, Y. Li et al., Risk Factors, and Outcomes of Clostridium difficile Infections in Kidney Transplant Recipients, Transplantation, vol.102, issue.9, pp.1576-1581, 2018.

J. Origüen, M. Fernández-ruiz, C. Lumbreras, M. Á. Orellana, F. López-medrano et al., Potential role of post-transplant hypogammaglobulinemia in the risk of Clostridium difficile infection after kidney transplantation: a case-control study, Infection, vol.43, issue.4, pp.413-435, 2015.

H. Yu, F. Higa, M. Koide, S. Haranaga, S. Yara et al., Lung Abscess Caused by Legionella Species: Implication of the Immune Status of Hosts, Internal Medicine, vol.48, issue.23, pp.1997-2002, 2009.

S. A. Pergam, C. W. Forsberg, M. J. Boeckh, C. Maynard, A. P. Limaye et al., Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients, Transplant Infectious Disease, vol.13, issue.1, pp.15-23, 2011.

J. A. Fishman, Pneumocystis carinii and parasitic infections in transplantation, Infect Dis Clin North Am, vol.9, issue.4, pp.1005-1049, 1995.

R. H. Rubin, Infection in the Organ Transplant Recipient, Clinical Approach to Infection in the Compromised Host

M. A. Boston and U. S. Springer, , pp.629-705, 1994.

L. A. Collins, M. H. Samore, M. S. Roberts, R. Luzzati, R. L. Jenkins et al., Risk factors for invasive fungal infections complicating orthotopic liver transplantation, J Infect Dis, vol.170, issue.3, pp.644-52, 1994.

C. Lumbreras, V. Cuervas-mons, P. Jara, A. Del-palacio, V. S. Turrión et al., Randomized Trial of Fluconazole versus Nystatin for the Prophylaxis of Candida Infection following Liver Transplantation, J Infect Dis, vol.174, issue.3, pp.583-591, 1996.

H. Einsele, P. Ljungman, and M. Boeckh, How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation, Blood, vol.135, pp.1619-1648, 2019.

L. S. Dalrymple, R. Katz, B. Kestenbaum, I. H. De-boer, L. Fried et al., The Risk of Infection-Related Hospitalization With Decreased Kidney Function, American Journal of Kidney Diseases, vol.59, issue.3, pp.356-63, 2012.

H. I. Mcdonald, S. L. Thomas, and D. Nitsch, Chronic kidney disease as a risk factor for acute communityacquired infections in high-income countries: a systematic review, BMJ Open, vol.4, issue.4, p.4100, 2014.

L. P. Fried, C. M. Tangen, J. Walston, A. B. Newman, C. Hirsch et al., Frailty in Older AdultsEvidence for a Phenotype, J Gerontol A Biol Sci Med Sci, vol.56, issue.3, pp.146-57, 2001.

K. N. Jeejeebhoy, Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features. Current Opinion in Clinical Nutrition & Metabolic Care, vol.15, pp.213-219, 2012.

I. Gandolfini, G. Regolisti, A. Bazzocchi, U. Maggiore, A. Palmisano et al., Frailty and Sarcopenia in Older Patients Receiving Kidney Transplantation. Front Nutr, vol.6, 2019.

M. A. Mcadams-demarco, A. Law, M. L. Salter, E. Chow, M. Grams et al., Frailty and Early Hospital Readmission After Kidney Transplantation, American Journal of Transplantation, vol.13, issue.8, pp.2091-2096, 2013.

P. Kotagiri, D. Chembolli, J. Ryan, P. D. Hughes, and N. D. Toussaint, Urinary Tract Infections in the First Year Post-Kidney Transplantation: Potential Benefits of Treating Asymptomatic Bacteriuria, Transplantation Proceedings, vol.49, pp.2070-2075, 2017.

R. Rivera-sanchez, D. Delgado-ochoa, R. R. Flores-paz, E. E. García-jiménez, R. Espinosa-hernández et al., Prospective study of urinary tract infection surveillance after kidney transplantation, BMC Infect Dis, vol.10, issue.1, p.245, 2010.

E. Masson, C. Vidal, M. Deschamps, S. Bongain, C. Thevenin et al., Incidence and risk factors of anti-HLA immunization after pregnancy, Human Immunology, vol.74, issue.8, pp.946-51, 2013.

M. Vilches and A. Nieto, Analysis of Pregnancy-Induced Anti-HLA Antibodies Using Luminex Platform. Transplantation Proceedings, vol.47, pp.2608-2618, 2015.

A. Bastidas, J. De-la-serna, E. Idrissi, M. Oostvogels, L. Quittet et al., Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial, JAMA, vol.322, issue.2, p.123, 2009.

K. C. Abbott, D. F. Cruess, L. Agodoa, E. S. Sawyers, and D. P. Tveit, Early renal insufficiency and late venous thromboembolism after renal transplantation in the united states1 1The opinions are solely those of the authors and do not represent an endorsement by the Department of Defense or The National Institutes of Health, American Journal of Kidney Diseases, vol.43, issue.1, pp.120-150, 2004.

N. N. Lam, A. X. Garg, G. A. Knoll, S. J. Kim, K. L. Lentine et al., Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients, AJN, vol.46, issue.4, pp.343-54, 2017.

A. Frederick, A. Spencer-frederick, and A. , Risk Factors for Venous Thromboembolism, Circulation, vol.107, issue.23_suppl_1, p.9, 2003.

V. R. Dharnidharka, D. M. Stablein, and W. E. Harmon, Post-Transplant Infections Now Exceed Acute Rejection as Cause for Hospitalization: A Report of the NAPRTCS1, American Journal of Transplantation, vol.4, issue.3, pp.384-393, 2004.

M. Möller, C. J. Kinnear, M. Orlova, E. E. Kroon, P. D. Van-helden et al., Genetic Resistance to Mycobacterium tuberculosis Infection and Disease. Front Immunol [Internet], vol.9, 2018.

J. Bustamante, Mendelian susceptibility to mycobacterial disease: recent discoveries, Hum Genet, vol.139, issue.6, pp.993-1000, 2020.

J. Casanova and L. Abel, Genetic Dissection of Immunity to Mycobacteria: The Human Model, Annual Review of Immunology, vol.20, issue.1, pp.581-620, 2002.

E. Mortaz, I. M. Adcock, P. Tabarsi, M. R. Masjedi, D. Mansouri et al., Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis, J Clin Immunol, vol.35, issue.1, pp.1-10, 2015.

L. Romani, Immunity to fungal infections, Nature Reviews Immunology, vol.4, issue.1, pp.11-24, 2004.

D. J. Taber, M. Hamedi, J. R. Rodrigue, M. G. Gebregziabher, T. R. Srinivas et al., Quantifying the Race Stratified Impact of Socioeconomics on Graft Outcomes in Kidney Transplant Recipients, Transplantation, vol.100, issue.7, p.1550, 2016.

J. Coussement, D. Lebeaux, C. Van-delden, H. Guillot, R. Freund et al., Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study, Clin Infect Dis, vol.63, issue.3, pp.338-383, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01608128

A. Stern, H. Green, M. Paul, L. Vidal, and L. Leibovici, Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database of Systematic Reviews, 2014.

. Cmv, . Vzv, and . Bk, 11 of the 550 patients infected with CMV presented a recurrence of the infection, and delay of infection by CMV was 174 days [64 ; 362] after transplantation. Most of them presented an hematological infection with 276 episodes (49.3%), followed by 198 digestive infections (35.2%), 33 (5.9%) pulmonary diseases and 29 (5.2%) disseminated infections. 531 patients presented a VZV infection and 24 of them presented a recurrence

, 1%) patients presented a disseminated VZV infection. 200 patients presented a total of 207 episodes of BK virus nephritis, and diagnosis delay was 295 days [134, vol.587

, 160 patients presented a gastro-intestinal norovirus infection and 12 of them presented a recurrence, delay between transplantation and diagnosis of the first episode was 1417 days

, 1%) and 4 gastro-intestinal corresponding to peritonitis. 20 cryptococcosis were diagnosed with a delay of 866, There was 12 fungemia (8.7%), 7 vascular infections, p.1